α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer

Journal of Biological Chemistry

Volumn 287, Issue 19, 2012, Pages 15345-15364

  Fauvet, Bruno ^a   Mbefo, Martial K ^a   Fares, Mohamed Bilal ^a   Desobry, Carole ^a   Michael, Sarah ^b   Ardah, Mustafa T ^c   Tsika, Elpida ^a   Coune, Philippe ^a   Prudent, Michel ^d   Lion, Niels ^d   Eliezer, David ^e   Moore, Darren J ^a   Schneider, Bernard ^a   Aebischer, Patrick ^a   El Agnaf, Omar M ^c   Masliah, Eliezer ^b   Lashuel, Hilal A ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^d Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEMS; COMPLEX MIXTURE; CONFORMATIONAL PROPERTIES; E. COLI; GEL ELECTROPHORESIS TECHNIQUE; HEK-293; HELICAL STRUCTURES; HUMAN BRAIN; MAMMALIAN CELL LINES; MAMMALIAN CELLS; MONOMERIC PROTEINS; OLIGOMERIC STATE; QUATERNARY STRUCTURE; RAT BRAIN; RED BLOOD CELL; SYNUCLEIN; TETRAMERS;

BIOLOGICAL MEMBRANES; CELL CULTURE; ELECTROPHORESIS; ESCHERICHIA COLI; MONOMERS; OLIGOMERS; PROTEINS; RATS; SIZE EXCLUSION CHROMATOGRAPHY;

CONFORMATIONS;

ALPHA SYNUCLEIN; MONOMER;

ALPHA HELIX; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CROSS LINKING; ERYTHROCYTE; ESCHERICHIA COLI; GEL ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; MAMMAL CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; RAT;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; ANIMALS; BRAIN; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM; CHROMATOGRAPHY, GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; ESCHERICHIA COLI; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNOBLOTTING; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN UNFOLDING; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

ESCHERICHIA COLI; MAMMALIA; RATTUS; RODENTIA;

EID: 84859577559     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.318949     Document Type: Article

References (73)

1. Bartels, T., Choi, J. G., and Selkoe, D. J. (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107-110
2. Wang, W., Perovic, I., Chittuluru, J., Kaganovich, A., Nguyen, L. T., Liao, J., Auclair, J. R., Johnson, D., Landeru, A., Simorellis, A. K., Ju, S., Cookson, M. R., Asturias, F. J., Agar, J. N., Webb, B. N., Kang, C., Ringe, D., Petsko, G. A., Pochapsky, T. C., and Hoang, Q. Q. (2011) A soluble α-synuclein construct forms a dynamic tetramer. Proc. Natl. Acad. Sci. 108, 17797-17802
3. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. 95, 6469-6473 (Pubitemid 28249037)
4. Baba, M., Nakajo, S., Tu, P. H., Tomita, T., Nakaya, K., Lee, V. M., Trojanowski, J. Q., and Iwatsubo, T. (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879-884 (Pubitemid 28173348)
5. Cookson, M. R. (2009) α-Synuclein and neuronal cell death. Mol. Neurodegener. 4, 9
6. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., and Lansbury, P. T., Jr. (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709-13715 (Pubitemid 26363912)
7. Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318-1320 (Pubitemid 28512115)
8. Chartier-Harlin, M. C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., Waucquier, N., Defebvre, L., Amouyel, P., Farrer, M., and Destée, A. (2004) α-Synuclein locus duplication as a cause of familial Parkinson disease. Lancet 364, 1167-1169 (Pubitemid 39296604)
9. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M. R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., and Gwinn- Hardy, K. (2003) α-Synuclein locus triplication causes Parkinson disease. Science 302, 841 (Pubitemid 37339619)
10. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I., and Nussbaum, R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson disease. Science 276, 2045-2047 (Pubitemid 27443610)
11. Zarranz, J. J., Alegre, J., Gómez-Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., Llorens, V., Gomez Tortosa, E., del Ser, T., Muñoz, D. G., and de Yebenes, J. G. (2004) The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173 (Pubitemid 38166992)
12. Muñoz, E., Oliva, R., Obach, V., Martí, M. J., Pastor, P., Ballesta, F., and Tolosa, E. (1997) Identification of Spanish familial Parkinson disease and screening for the A53T mutation of the α-synuclein gene in early onset patients. Neurosci. Lett. 235, 57-60 (Pubitemid 27471104)
13. Duda, J. E., Giasson, B. I., Chen, Q., Gur, T. L., Hurtig, H. I., Stern, M. B., Gollomp, S. M., Ischiropoulos, H., Lee, V. M., and Trojanowski, J. Q. (2000) Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am. J. Pathol. 157, 1439-1445
14. Giasson, B. I., Duda, J. E., Murray, I. V., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., and Lee, V. M. (2000) Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 290, 985-989
15. Souza, J. M., Giasson, B. I., Chen, Q., Lee, V. M., and Ischiropoulos, H. (2000) Dityrosine cross-linking promotes formation of stable α-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275, 18344-18349 (Pubitemid 30414790)
16. Yamin, G., Uversky, V. N., and Fink, A. L. (2003) Nitration inhibits fibrillation of human α-synuclein in vitro by formation of soluble oligomers. FEBS Lett. 542, 147-152 (Pubitemid 36555731)
17. Binolfi, A., Rasia, R. M., Bertoncini, C. W., Ceolin, M., Zweckstetter, M., Griesinger, C., Jovin, T. M., and Fernández, C. O. (2006) Interaction of α-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity, and fibrillation enhancement. J. Am. Chem. Soc. 128, 9893-9901 (Pubitemid 44147975)
18. Santner, A., and Uversky, V. N. (2010) Metalloproteomics and metal toxicology of α-synuclein. Metallomics 2, 378-392
19. Lücking, C. B., and Brice, A. (2000) α-Synuclein and Parkinson disease. Cell. Mol. Life Sci. 57, 1894-1908
20. Uversky, V. N., and Eliezer, D. (2009) Biophysics of Parkinson disease. Structure and aggregation of α-synuclein. Curr. Protein Pept. Sci. 10, 483-499
21. Ringrose, J. H., van Solinge, W. W., Mohammed, S., O'Flaherty, M. C., van Wijk, R., Heck, A. J., and Slijper, M. (2008) Highly efficient depletion strategy for the two most abundant erythrocyte-soluble proteins improves proteome coverage dramatically. J. Proteome Res. 7, 3060-3063
22. Han, V., Serrano, K., and Devine, D. V. (2010) A comparative study of common techniques used to measure hemolysis in stored red cell concentrates. Vox Sang. 98, 116-123
23. Eliezer, D., Kutluay, E., Bussell, R., Jr., and Browne, G. (2001) Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061-1073 (Pubitemid 33029953)
24. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe. A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 277-293
25. Johnson, B. A., and Blevins, R. A. (1994) NMRView. A Computer Program for the Visualization and Analysis of NMR Data. J. Biomol. NMR 4, 603-614
26. 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR 6, 135-140
27. Tinsley, R. B., Kotschet, K., Modesto, D., Ng, H., Wang, Y., Nagley, P., Shaw, G., and Horne, M. K. (2010) Sensitive and specific detection of α-synuclein in human plasma. J. Neurosci. Res. 88, 2693-2700
28. Perrin, R. J., Payton, J. E., Barnett, D. H., Wraight, C. L., Woods, W. S., Ye, L., and George, J. M. (2003) Epitope mapping and specificity of the anti-α-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines. Neurosci. Lett. 349, 133-135 (Pubitemid 37297831)
29. Mbefo, M. K., Paleologou, K. E., Boucharaba, A., Oueslati, A., Schell, H., Fournier, M., Olschewski, D., Yin, G., Zweckstetter, M., Masliah, E., Kahle, P. J., Hirling, H., and Lashuel, H. A. (2010) Phosphorylation of synucleins by members of the Polo-like kinase family. J. Biol. Chem. 285, 2807-2822
30. Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., and Price, D. L. (2002) Human α-synuclein-harboring familial Parkinson disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. 99, 8968-8973 (Pubitemid 34693667)
31. Rockenstein, E. M., McConlogue, L., Tan, H., Power, M., Masliah, E., and Mucke, L. (1995) Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer disease. J. Biol. Chem. 270, 28257-28267
32. Dusonchet, J., Bensadoun, J. C., Schneider, B. L., and Aebischer, P. (2009) Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson disease. Neurobiol Dis 35, 32-41
33. Lennox, G., Lowe, J., Landon, M., Byrne, E. J., Mayer, R. J., and Godwin-Austen, R. B. (1989) Diffuse Lewy body disease. Correlative neuropathology using anti-ubiquitin immunocytochemistry. J. Neurol. Neurosurg. Psychiatry 52, 1236-1247 (Pubitemid 20002862)
34. Pham, E., Crews, L., Ubhi, K., Hansen, L., Adame, A., Cartier, A., Salmon, D., Galasko, D., Michael, S., Savas, J. N., Yates, J. R., Glabe, C., and Masliah, E. (2010) Progressive accumulation of amyloid-α oligomers in Alzheimer disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J. 277, 3051-3067
35. Anderson, J. P., Walker, D. E., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., Diep, L., Keim, P. S., Shen, X., Chataway, T., Schlossmacher, M. G., Seubert, P., Schenk, D., Sinha, S., Gai, W. P., and Chilcote, T. J. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739-29752 (Pubitemid 44536983)
36. Ohrfelt, A., Zetterberg, H., Andersson, K., Persson, R., Secic, D., Brinkmalm, G., Wallin, A., Mulugeta, E., Francis, P. T., Vanmechelen, E., Aarsland, D., Ballard, C., Blennow, K., and Westman-Brinkmalm, A. (2011) Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem. Res. 36, 2029-2042
37. Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., and Saitoh, T. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. 90, 11282-11286 (Pubitemid 23354413)
38. Jakes, R., Spillantini, M. G., and Goedert, M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27-32 (Pubitemid 24154659)
39. Anderson, V. L., Ramlall, T. F., Rospigliosi, C. C., Webb, W. W., and Eliezer, D. (2010) Identification of a helical intermediate in trifluoroethanol-induced α-synuclein aggregation. Proc. Natl. Acad. Sci. 107, 18850-18855
40. Bussell, R., Jr., and Eliezer, D. (2001) Residual structure and dynamics in Parkinson disease-associated mutants of α-synuclein. J. Biol. Chem. 276, 45996-46003
41. Georgieva, E. R., Ramlall, T. F., Borbat, P. P., Freed, J. H., and Eliezer, D. (2008) Membrane-bound α-synuclein forms an extended helix. Long distance pulsed ESR measurements using vesicles, bicelles, and rod-like micelles. J. Am. Chem. Soc. 130, 12856-12857
42. Georgieva, E. R., Ramlall, T. F., Borbat, P. P., Freed, J. H., and Eliezer, D. (2010) The lipid-binding domain of wild type and mutant α-synuclein. Compactness and interconversion between the broken and extended helix forms. J. Biol. Chem. 285, 28261-28274
43. Paleologou, K. E., Oueslati, A., Shakked, G., Rospigliosi, C. C., Kim, H. Y., Lamberto, G. R., Fernandez, C. O., Schmid, A., Chegini, F., Gai, W. P., Chiappe, D., Moniatte, M., Schneider, B. L., Aebischer, P., Eliezer, D., Zweckstetter, M., Masliah, E., and Lashuel, H. A. (2010) Phosphorylation at Ser-87 is enhanced in synucleinopathies, inhibits α-synuclein oligomerization, and influences synuclein-membrane interactions. J. Neurosci. 30, 3184-3198
44. Paleologou, K. E., Schmid, A. W., Rospigliosi, C. C., Kim, H. Y., Lamberto, G. R., Fredenburg, R. A., Lansbury, P. T., Jr., Fernandez, C. O., Eliezer, D., Zweckstetter, M., and Lashuel, H. A. (2008) Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein. J. Biol. Chem. 283, 16895-16905
45. Rospigliosi, C. C., McClendon, S., Schmid, A. W., Ramlall, T. F., Barré, P., Lashuel, H. A., and Eliezer, D. (2009) E46K Parkinson-linked mutation enhances C-terminal to N-terminal contacts in α-synuclein. J. Mol. Biol. 388, 1022-1032
46. Sung, Y. H., and Eliezer, D. (2007) Residual structure, backbone dynamics, and interactions within the synuclein family. J. Mol. Biol. 372, 689-707
47. Croke, R. L., Sallum, C. O., Watson, E., Watt, E. D., and Alexandrescu, A. T. (2008) Hydrogen exchange of monomeric α-synuclein shows unfolded structure persists at physiological temperature and is independent of molecular crowding in Escherichia coli. Protein Sci. 17, 1434-1445
48. Fernández, C. O., Hoyer, W., Zweckstetter, M., Jares-Erijman, E. A., Subramaniam, V., Griesinger, C., and Jovin, T. M. (2004) NMR of α-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J. 23, 2039-2046 (Pubitemid 38737731)
49. Li, C., Lutz, E. A., Slade, K. M., Ruf, R. A., Wang, G. F., and Pielak, G. J. (2009) 19FNMRstudies of α-synuclein conformation and fibrillation. Biochemistry 48, 8578-8584
50. McNulty, B. C., Tripathy, A., Young, G. B., Charlton, L. M., Orans, J., and Pielak, G. J. (2006) Temperature-induced reversible conformational change in the first 100 residues of α-synuclein. Protein Sci. 15, 602-608
51. Rasia, R. M., Bertoncini, C. W., Marsh, D., Hoyer, W., Cherny, D., Zweckstetter, M., Griesinger, C., Jovin, T. M., and Fernández, C. O. (2005) Structural characterization of copper(II) binding to α-synuclein. Insights into the bioinorganic chemistry of Parkinson disease. Proc. Natl. Acad. Sci. 102, 4294-4299 (Pubitemid 40397105)
52. Segers-Nolten, I. M., Wilhelmus, M. M., Veldhuis, G., van Rooijen, B. D., Drukarch, B., and Subramaniam, V. (2008) Tissue transglutaminase modulates α-synuclein oligomerization. Protein Sci. 17, 1395-1402
53. Wu, K. P., Weinstock, D. S., Narayanan, C., Levy, R. M., and Baum, J. (2009) Structural reorganization of α-synuclein at low pH observed by NMR and REMD simulations. J. Mol. Biol. 391, 784-796
54. Azeredo da Silveira, S., Schneider, B. L., Cifuentes-Diaz, C., Sage, D., Abbas-Terki, T., Iwatsubo, T., Unser, M., and Aebischer, P. (2009) Phosphorylation does not prompt, nor prevent, the formation of α-synuclein toxic species in a rat model of Parkinson disease. Hum. Mol. Genet. 18, 872-887
55. El-Agnaf, O. M., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G., and Allsop, D. (2006) Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J. 20, 419-425 (Pubitemid 44933318)
56. Lee, D., Lee, E. K., Lee, J. H., Chang, C. S., and Paik, S. R. (2001) Selfoligomerization and protein aggregation of α-synuclein in the presence of Coomassie Brilliant Blue. Eur. J. Biochem. 268, 295-301 (Pubitemid 32862659)
57. Paik, S. R., Shin, H. J., Lee, J. H., Chang, C. S., and Kim, J. (1999) Copper(II)-induced self-oligomerization of α-synuclein. Biochem. J. 340, 821-828
58. Cole, N. B., Murphy, D. D., Grider, T., Rueter, S., Brasaemle, D., and Nussbaum, R. L. (2002) Lipid droplet binding and oligomerization properties of the Parkinson disease protein α-synuclein. J. Biol. Chem. 277, 6344-6352 (Pubitemid 34968427)
59. Shaikh, S., and Nicholson, L. F. (2008) Advanced glycation end products induce in vitro cross-linking of α-synuclein and accelerate the process of intracellular inclusion body formation. J. Neurosci. Res. 86, 2071-2082
60. Walker, J. M. (2002) The Protein Protocols Handbook 200, Part II, pp. 57-60, Humana Press, Totowa, NJ
61. Selkoe, D., Choi, J., Kim, N., and Bartels, T. (2011) Nondenaturing purification of α-synuclein from erythrocytes. Protocol Exchange
62. Smith, D. B., and Johnson, K. S. (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40
63. Lim, K., Ho, J. X., Keeling, K., Gilliland, G. L., Ji, X., Rüker, F., and Carter, D. C. (1994) Three-dimensional structure of Schistosoma japonicum glutathione S-transferase fused with a six-amino acid conserved neutralizing epitope of gp41 from HIV. Protein Sci. 3, 2233-2244
64. Parker, M. W., Lo Bello, M., and Federici, G. (1990) Crystallization of glutathione S-transferase from human placenta. J. Mol. Biol. 213, 221-222 (Pubitemid 20176532)
65. Ji, X., Zhang, P., Armstrong, R. N., and Gilliland, G. L. (1992) The threedimensional structure of a glutathione S-transferase from the mu gene class. Structural analysis of the binary complex of isoenzyme 3-3 and glutathione at 2.2-Å resolution. Biochemistry 31, 10169-10184
66. Ferguson, K. A. (1964) Starch gel electrophoresis. Application to the classification of pituitary proteins and polypeptides. Metabolism 13, 985-1002
67. Wu, K. P., Kim, S., Fela, D. A., and Baum, J. (2008) Characterization of conformational and dynamic properties of natively unfolded human and mouse α-synuclein ensembles by NMR. Implication for aggregation. J. Mol. Biol. 378, 1104-1115
68. Marsh, J. A., Singh, V. K., Jia, Z., and Forman-Kay, J. D. (2006) Sensitivity of secondary structure propensities to sequence differences between α- and γ-synuclein. Implications for fibrillation. Protein Sci. 15, 2795-2804 (Pubitemid 44833760)
69. Bertoncini, C. W., Fernandez, C. O., Griesinger, C., Jovin, T. M., and Zweckstetter, M. (2005) Familial mutants of α-synuclein with increased neurotoxicity have a destabilized conformation. J. Biol. Chem. 280, 30649-30652 (Pubitemid 41291792)
70. Kang, J. H., and Kim, K. S. (2003) Enhanced oligomerization of the α-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system. Mol. Cells 15, 87-93 (Pubitemid 41582947)
71. Krishnan, S., Chi, E. Y., Wood, S. J., Kendrick, B. S., Li, C., Garzon-Rodriguez, W., Wypych, J., Randolph, T. W., Narhi, L. O., Biere, A. L., Citron, M., and Carpenter, J. F. (2003) Oxidative dimer formation is the critical rate-limiting step for Parkinson disease α-synuclein fibrillogenesis. Biochemistry 42, 829-837 (Pubitemid 36133308)
72. Dedmon, M. M., Lindorff-Larsen, K., Christodoulou, J., Vendruscolo, M., and Dobson, C. M. (2005) Mapping long range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J. Am. Chem. Soc. 127, 476-477 (Pubitemid 40174345)
73. Oueslati, A., Paleologou, K. E., Schneider, B. L., Aebischer, P., and Lashuel, H. A. (2012) Mimicking phosphorylation at serine 87 inhibits the aggregation of human α-synuclein and protects against its toxicity in a rat model of Parkinson disease. J. Neurosci. 32, 1536-1544